Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer


Ris-Rez cuts progression risk by 67% in Phase III relapsed osteosarcoma trial


Olomorasib shows durable first-line activity in KRAS G12C-mutant lung cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Machine Learning in Bioprocess Development: Where We Are and Where We Could Go

Presented by Rui Portela, Senior Data Scientist, GlaxoSmithKline Vaccines and Klaus Mauch, CEO at Insilico Biotechnology AG
06th May 2020


Qualification of Raw Materials Used In the Manufacturing of Cellular Therapies

Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia and Horst Ruppach, Ph.D. Scientific Director Viral Safety at Charles River
07th October 2019


Points to consider when defining a microbial control strategy for individualized ATMPs

Presented by Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy)
05th April 2023


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia